| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4203866 | Archivos de Bronconeumología | 2011 | 8 Pages |
Abstract
Changes were observed in different pulmonary and systemic inflammatory markers during ECOPD, that were not completely resolved during stability. However, current treatment does not allow the modification of HDAC activity, which limits its anti-inflammatory effects.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Ana L. Kersul, Amanda Iglesias, Ángel RÃos, Aina Noguera, Aina Forteza, Enrique Serra, Alvar AgustÃ, Borja G. CosÃo,